Medical/Pharmaceuticals Global News & Press Release Distribution

Medical/Pharmaceuticals

All
APAC

111, Inc. Announces Second Quarter 2020 Unaudited Financial Results

SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a company dedicated to digitally connecting patients with drugs and healthcare services inChina, today announced its unaudited financial results for the second quarter endedJune 30, 2020. Second Quarter 2020...

2020-08-20 16:35 11555

PharmAbcine announces the execution of a Material Cooperative Research and Development Agreement (MCRADA) with the NIH to evaluate the efficacy of PMC-403 to treat SCLS

DAEJEON, South Korea, Aug. 18, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a Materials Cooperative Research and Development Agreement (MCRADA) with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), in whic...

2020-08-18 21:00 8634

Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results

HONG KONG, Aug. 18, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...

2020-08-18 19:00 3889

Koichiro Matsumoto Appointed President/CEO of Bushu Pharmaceuticals Ltd.

KAWAGOE, Japan, Aug. 18, 2020 /PRNewswire/ -- In response to requests for a professional contract development and manufacturing organization (CDMO) partner inAsia that can better meet the needs and challenges of the global market, Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") appointed ...

2020-08-18 14:00 1752

China Biologic Reports Financial Results for the Second Quarter of 2020

BEIJING, Aug. 17, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the second quarter of 2020. Second Quart...

2020-08-18 04:30 9902

I-Mab Announces First Patient Dosed in Phase 1b Study of Plonmarlimab in Rheumatoid Arthritis in China

SHANGHAI and GAITHERSBERG, Md., Aug. 17, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed with plonmarlimab ...

2020-08-17 20:00 3567

CARsgen Announces the Publication of a Novel CAR-T Technology that Improves the Efficacy of CAR-T cells Against Solid Tumors without Requiring Preconditioned Lymphodepletion

SHANGHAI, Aug. 17, 2020 /PRNewswire/ -- CARsgen Therapeutics, a leader in developing novel CAR-T cell therapies against solid tumors, today announced its publication of the 7×21 CAR-T technology in CLINICAL CANCER RESEARCH. The article is titled "Coexpression of IL-7 and CCL21 increases efficacy ...

2020-08-17 18:00 4023

China Pharma Holdings, Inc. Reports Second Quarter 2020 Financial Results

HAIKOU CITY, China, Aug. 14, 2020 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the qu...

2020-08-14 18:30 5966

Bushu Pharmaceuticals Announces Major Expansion Program

KAWAGOE, Japan, Aug. 14, 2020 /PRNewswire/ -- - Japan's Premier CDMO Will Invest $100m to Expand Capacity and Portfolio - Bushu Pharmaceuticals Ltd., one of Japan's largest contract manufacturers of pharmaceutical products, announced onAugust 14 a major capital program costing $100 million to ex...

2020-08-14 14:00 2563

Hankyung.com's introduces: "Seoul Made" PPE kits, targeting US Market

SEOUL, South Korea, Aug. 13, 2020 /PRNewswire/ -- "Seoul Made" PPE kits designed with Korean cultural themes and made by small businesses inSeoul, was delivered to New York on August 13th With many stakeholders of New Jersey, New York, Brooklyn, Chamber of Commerce, and other related agencies e...

2020-08-14 08:00 1944

WuXi AppTec Achieved Strong Growth in First-Half of 2020 with China Sites Resuming Full Operations

WuXi AppTec Second-Quarter 2020 Results Revenue Up 29.4% YoY to RMB4,044 Million Net Profit Attributable to Owners of the Company Up 111.0% YoY to RMB1,414 Million Diluted EPS Up 110.3% YoY to RMB0.61 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 43.1% YoY toRMB942 Million...

2020-08-13 16:49 5117

United Imaging, Debuting at AHRA as a Gold Sponsor, Announces FDA Clearance of Its Latest Deep Learning Reconstruction Technology, uAI HYPER DLR

HOUSTON, Aug. 11, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has received FDA clearance for uAI HYPER DLR (Deep Learning Reconstruction), an advanced image processing function intended to reduce the noise of fluorodeoxyglucose (FDG...

2020-08-12 00:00 1835

CPHI to Hold Second Quarter 2020 Earnings Conference Call On Friday August 14, 2020 at 8:30 a.m. ET

HAIKOU CITY, China, Aug. 11, 2020 /PRNewswire/ -- China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its 2n...

2020-08-11 22:10 5990

New Study Proves Asclepius Meditec's Hydrogen Oxygen Generator Helps Improve COVID-19 Disease Severity and Dyspnea

SHANGHAI, Aug. 10, 2020 /PRNewswire/ -- An innovative, environmentally friendly treatment with no side effects has been made available to COVID-19 patients, involving the electrolysis of H2O to produce a mixture of hydrogen and oxygen for human inhalation. The results of the research as a treatme...

2020-08-10 21:00 2804

New Study Proves Asclepius Meditec's Hydrogen Oxygen Generator Helps Improve COVID-19 Disease Severity and Dyspnea

Fapon 2nd COVID-19 Donation, 100 Million Anti-SARS-CoV-2 Fully Human RBD IgM & IgG QC Test Materials

DONGGUAN, China, Aug. 10, 2020 /PRNewswire/ -- Fapon Biotech Inc . (Fapon), a global leading IVD raw materials and one-stop solutions company, announces a new COVID-19 donation to meet the urgent demand for development and optimization of reliable quality controls for high-...

2020-08-10 20:00 1905

Fapon 2nd COVID-19 Donation, 100 Million Anti-SARS-CoV-2 Fully Human RBD IgM & IgG QC Test Materials

China Biologic Products to Report Second Quarter 2020 Financial Results

BEIJING, Aug. 10, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its second quarter 2020 financial results ...

2020-08-10 20:00 8871

Co-Diagnostics, Inc. Logix Smart™ COVID-19 Test Authorized for Use in Australia

SALT LAKE CITY, Aug. 7, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today thatAustralia has been added to the list of countries that have authorized the Logix Smart™ C...

2020-08-07 18:30 9130

CMAB Appoints Ms. Maggie Chen as Chief Financial Officer

SUZHOU, China, Aug. 6, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), a dedicated biologics contract manufacturing and development organization (CDMO), today announced the appointment of Ms.Maggie Chen as the chief financial officer. Ms. Chen will lay a solid foundation for the long-...

2020-08-07 08:00 4612

CMAB Appoints Ms. Maggie Chen as Chief Financial Officer

ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies

SHENZHEN and SHANGHAI, August 6, 2020 /PRNewswire/ -- ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd today announced a clinical collaboration and exclusive license agreement for ImmVira's MVR-T3011 intratumoral oncolytic virus program for the commercialization of novel immun...

2020-08-06 23:49 9547

ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies

I-Mab to Report Financial Results for the Six Months Ended June 30, 2020 and Provide Corporate Update on August 31, 2020

SHANGHAI and GAITHERSBURG, Md., Aug. 6, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that it will report financial results for the six months ...

2020-08-06 20:30 14829

1 ... 193 194 195196197 198 199 ... 213